Literature DB >> 31372290

Effects of preoperative sarcopenia on postoperative complications of minimally invasive oesophagectomy for oesophageal squamous cell carcinoma.

Jinxin Xu1, Bin Zheng1, Shuliang Zhang1, Taidui Zeng1, Hao Chen1, Wei Zheng1, Chun Chen1.   

Abstract

BACKGROUND: Sarcopenia is closely associated with surgical complications in patients with certain cancers. In this study we assessed the relationship between sarcopenia and postoperative complications in patients with oesophageal squamous cell carcinoma.
METHODS: We retrospectively analysed of patients who underwent thoracoscopic combined with laparoscopic radical resection of oesophageal cancer. Preoperative computed tomography to evaluate skeletal muscle mass to diagnose sarcopenia and to evaluate associations with age, body mass index (BMI), lung function and postoperative complications.
RESULTS: Among 141 patients, 73 presented with sarcopenia (sarcopenia group) and 68 did not (non-sarcopenia group). The mean skeletal muscle index in all patients was 49.5±9.0 cm2/m2; median, 49.3 cm2/m2. The sarcopenia group included a higher proportion of men (P=0.039) and had a lower BMI than the non-sarcopenia group (P=0.001). There were no significant differences in any other clinical and pathological features. The incidences of postoperative complications in the sarcopenia and non-sarcopenia groups were 63.0% and 36.8%, respectively (P=0.002). The incidences of pulmonary infections and postoperative pleural effusions were 28.8% vs. 11.8% (P=0.011) and 38.4% vs. 20.6% (P=0.020) in the sarcopenia and non-sarcopenia groups, respectively. The incidences of other complications were not significantly different between the two groups. Univariate and multivariate analyses of pulmonary infection-related clinical factors revealed that sarcopenia and forced expiratory volume in the first second as a percent of forced vital capacity (FEV1.0%) were independent risk factors for pulmonary infection after minimally invasive surgery.
CONCLUSIONS: Preoperative sarcopenia is an independent risk factor for pulmonary infection after minimally invasive oesophagectomy (MIE). Evaluation of preoperative sarcopenia will thus help to prevent postoperative complications.

Entities:  

Keywords:  Sarcopenia; oesophageal squamous cell carcinoma; postoperative complications; pulmonary infection

Year:  2019        PMID: 31372290      PMCID: PMC6626787          DOI: 10.21037/jtd.2019.05.55

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  34 in total

Review 1.  Body composition measurements during wasting diseases.

Authors:  C Pichard; U G Kyle
Journal:  Curr Opin Clin Nutr Metab Care       Date:  1998-07       Impact factor: 4.294

2.  [Correlations of preoperative pulmonary function tests for esophageal cancer to postoperative acute respiratory distress syndrome].

Authors:  Li-Xia Liu; Zhen-Jie Hu; Chai Zhao
Journal:  Ai Zheng       Date:  2006-03

3.  The Clavien-Dindo classification of surgical complications: five-year experience.

Authors:  Pierre A Clavien; Jeffrey Barkun; Michelle L de Oliveira; Jean Nicolas Vauthey; Daniel Dindo; Richard D Schulick; Eduardo de Santibañes; Juan Pekolj; Ksenija Slankamenac; Claudio Bassi; Rolf Graf; René Vonlanthen; Robert Padbury; John L Cameron; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

4.  Body composition and outcome in patients undergoing resection of colorectal liver metastases.

Authors:  M G van Vledder; S Levolger; N Ayez; C Verhoef; T C K Tran; J N M Ijzermans
Journal:  Br J Surg       Date:  2012-01-13       Impact factor: 6.939

5.  Elevated expression of inducible nitric oxide synthase and inflammatory cytokines in the alveolar macrophages after esophagectomy.

Authors:  Kunihiko Kooguchi; Atsuko Kobayashi; Yoshihiro Kitamura; Hiroshi Ueno; Yoji Urata; Hideki Onodera; Satoru Hashimoto
Journal:  Crit Care Med       Date:  2002-01       Impact factor: 7.598

6.  Prediction of major pulmonary complications after esophagectomy.

Authors:  Mark K Ferguson; Amy D Celauro; Vivek Prachand
Journal:  Ann Thorac Surg       Date:  2011-05       Impact factor: 4.330

7.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

8.  Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.

Authors:  Carla M M Prado; Jessica R Lieffers; Linda J McCargar; Tony Reiman; Michael B Sawyer; Lisa Martin; Vickie E Baracos
Journal:  Lancet Oncol       Date:  2008-06-06       Impact factor: 41.316

9.  Preoperative prediction of the occurrence and severity of complications after esophagectomy for cancer with use of a nomogram.

Authors:  Sjoerd M Lagarde; Johannes B Reitsma; Anna-Karin D Maris; Mark I van Berge Henegouwen; Olivier R C Busch; Hugo Obertop; Aelko H Zwinderman; J Jan B van Lanschot
Journal:  Ann Thorac Surg       Date:  2008-06       Impact factor: 4.330

10.  L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)--a randomized multicentre trial.

Authors:  Matthias Kraft; Kathleen Kraft; Simone Gärtner; Julia Mayerle; Peter Simon; Eckhard Weber; Kerstin Schütte; Jens Stieler; Heide Koula-Jenik; Peter Holzhauer; Uwe Gröber; Georg Engel; Cornelia Müller; You-Shan Feng; Ali Aghdassi; Claudia Nitsche; Peter Malfertheiner; Maciej Patrzyk; Thomas Kohlmann; Markus M Lerch
Journal:  Nutr J       Date:  2012-07-23       Impact factor: 3.271

View more
  1 in total

1.  Sarcopenia is poor risk for unfavorable short- and long-term outcomes in stage I non-small cell lung cancer.

Authors:  Yusuke Takahashi; Shigeki Suzuki; Kenichi Hamada; Takeo Nakada; Yuko Oya; Noriaki Sakakura; Hirokazu Matsushita; Hiroaki Kuroda
Journal:  Ann Transl Med       Date:  2021-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.